---
authors:
- Shaughnessy, Allen F
category: Case Study
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/36260878/
file_path: 2022/10/sglt-2-inhibitors-reduce-heart-failure-related-hospitalizati.md
issue: '4'
keywords:
- Diabetes Mellitus, Type 2
- Heart Failure
- Humans
- Diabetes
- Hospitalization
- Sodium-Glucose Transporter 2 Inhibitors
- Hypoglycemic Agents
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Sodium-Glucose Transporter 2 Inhibitors
- Hypoglycemic Agents
- Diabetes Mellitus, Type 2
- Heart Failure
- Hospitalization
original_format: PubMed
pages: 461-462
patient_population: Adults
peer_reviewed: true
pmid: '36260878'
processed_date: '2025-07-30'
publication_date: '2022-10-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-08-09'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: SGLT-2 Inhibitors Reduce Heart Failure-Related Hospitalization in Patients
  Without Diabetes.
topics:
- Diabetes Mellitus
- Endocrinology
- Family Medicine
- Metabolic Disorders
volume: '106'
publication_types: &id001
- Journal Article
pubmed_content_enriched: true
pubmed_full_data:
  pmid: '36260878'
  title: SGLT-2 Inhibitors Reduce Heart Failure-Related Hospitalization in Patients
    Without Diabetes.
  authors:
  - last_name: Shaughnessy
    fore_name: Allen F
    initials: AF
    affiliation: Tufts University, Boston, Mass.
  journal_info:
    title: American family physician
    iso_abbreviation: Am Fam Physician
    volume: '106'
    issue: '4'
  publication_info:
    year: '2022'
    month: '10'
    full_date: '2022-10-01'
  article_ids: {}
  mesh_terms:
  - descriptor: Humans
    major_topic: false
  - descriptor: Sodium-Glucose Transporter 2 Inhibitors
    major_topic: true
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
  - descriptor: Hypoglycemic Agents
    major_topic: false
    qualifiers:
    - qualifier: therapeutic use
      major_topic: false
    - qualifier: pharmacology
      major_topic: false
  - descriptor: Diabetes Mellitus, Type 2
    major_topic: true
    qualifiers:
    - qualifier: complications
      major_topic: false
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Heart Failure
    major_topic: true
    qualifiers:
    - qualifier: drug therapy
      major_topic: false
  - descriptor: Hospitalization
    major_topic: false
  publication_types: *id001
---

# SGLT-2 Inhibitors Reduce Heart Failure-Related Hospitalization in Patients Without Diabetes.

**Authors:** Shaughnessy, Allen F

**Published in:** American family physician | Vol. 106, No. 4 | 2022-10-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/36260878/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Diabetes Mellitus, Endocrinology, Family Medicine, Metabolic Disorders

## MeSH Terms

Humans, Sodium-Glucose Transporter 2 Inhibitors, Hypoglycemic Agents, Diabetes Mellitus, Type 2, Heart Failure, Hospitalization

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/36260878/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
